.alpha.-amino-indole-3-acetic acids useful as anti-diabetic, ant

Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

548465, 548504, 548507, C07D40706, C07D20920, C07D20906, C07D20922, C07D

Patent

active

052450465

DESCRIPTION:

BRIEF SUMMARY
BACKGROUND OF THE INVENTION

The present invention provides novel compounds. More particularly, the present invention provides novel .alpha.-amino-indole-3-acetic acids, tryptophans and their derivatives. The compounds are useful as anti-diabetic, anti-obesity and anti-atherosclerotic agents.


INFORMATION DISCLOSURE

.alpha.-Amino-indole-3-acetic acid, tryptophan and some of their derivatives are described in the literature. Thus, U.S. Pat. No. 3,074,942 discloses .alpha.-amino-indole-3-acetic acid and derivatives thereof that are described as being useful as anaesthetics, CNS depressants and as antagonists to serotonin, acetylcholine and histamine. Some of these same compounds are disclosed in U.S. Pat. No. 4,492,694, to Baker, J. W., Journal of Chemical Society, 458 (1940); Casnati et al, Gazz Chim. Ital., 93, 355 (1963); Dawes et al, Nature, 164, 705 (1949); Netherland published application 6,607,754; Armstrong et al, J. Biol. Chem., 232, 17 (1958).
U.S. Pat. No. 4,492,694 discloses acylated .alpha.-amino derivatives of .alpha.-amino-indole acetic acid.
U.S. Pat. No. 3,320,280, Netherland application 6,415,318, U.S. Pat. No. 3,316,260 and British patent 1,087,359 disclose .alpha.-(3-indolyl)lower aliphatic acid derivatives that contain a methyl substituent at the 2-position of the indole ring. Another feature of the compounds disclosed in U.S. Pat. No. 3,320,280 is the presence of an aromatic carboxylic acyl radical of less than three fused rings attached to the nitrogen atom of the indole ring.
U.S. Pat. No. 3,000,888 and Biekert et al, Ber., 97, 363 (1964) discloses an .alpha.-amino-indole-3-acetic acid derivative in which morpholino has been substituted for the .alpha.-amino group. It is described as being a therapeutic agent and an intermediate for preparing therapeutic agents.
German Offn. 2,345,775 and European patent application 7,615 published Feb. 6, 1980 discloses .alpha.-amino-indole-3-acetic acid derivatives having methyl and ethenyl substituents respectively, on .alpha.-carbon.
Yoneda, N., Chem. Pharm. Bull. 13, 1231 (1965), Kametani et al, J. Heterocycl. Chem., 5, 799 (1968), French patent 1,100,016 and Yamada et al, Chem. Pharm. Bull., 13, 88 (1965) disclose tryptophan derivatives in which one or both of the nitrogen atoms have been alkylated.
Preobrazhenskaya et al. Khim. Geterotsikl. Soedin, 7, 778 (1971) discloses tryptophan derivatives wherein the carboxylic acid group has been replaced by a hydroxyl, alkoxyl or benzyloxy group.
To applicants' knowledge, tryptophan is the only indole .alpha.-amino acid for which blood sugar altering effects have been reported.
Tryptophan reduced blood sugar levels in normal rats but not in rats with severe alloxan diabetes. Mirsky et al, Endocrinology, 59, 369 (1956) and Endocrinology, 6, 3180 (1957).
L-Tryptophan (2.5 mmoles/kg) administered i.p. to fasted rats blocked epinephrine-induced hyperglycemia 76%-89% and inhibited epinephrine-induced hyperglycemia to the same extent in both intact and diabetic rats indicatin that insulin was not involved in preventing the hyperglycemic response. Sanders et al, Pharmacology, 6, 155 (1971).
Fasting blood glucose levels were not affected by intragastric administration (120 mg/rat) of DL-tryptophan to female rats. The rise in blood glucose following glucose ingestion (1 g/rat) was decreased by DL-tryptophan as compared with rats receiving glucose only. Szigeti et al, Nahrung, 13, 171 (1969).
It was reported that tryptophan administered through the stomach does not produce hyperglycemia. Bedo et al, Egeszegtudomany, 13, 249 (1969).
Tryptophan facilitated deposition of glycogen, increased the liver weight, but decreased the pyruvate incorporation 7.5 times into liver glycogen. Lutkic et al, Bull. Sci., Cons., Acad. Sci. Arts RSF yougoslavie, Sect. A., 18, 8 (1973).
The oral administration of 10 g L-tryptophan to healthy human subjects induced a small but significant rise in blood sugar, a slight increase in blood insulin, a marked increase in plasma glucagon, and delayed increase in plasma growth hormone. This c

REFERENCES:
patent: 2542869 (1951-02-01), Hoffman
patent: 3000888 (1961-09-01), Beikert
patent: 3074942 (1963-01-01), Juhl et al.
patent: 3316260 (1967-04-01), Shen et al.
patent: 3320280 (1987-05-01), Gal et al.
patent: 4492694 (1985-10-01), Blaszczak et al.
Derwent 89-089908/12.
Baker, John W., "Syntheses in the Indole Series", Journal of Chemical Society, pp. 458-460, (1940).
E. A. Dawes et al, "Metal Catalysis of Indole Production", Nature, 164, 705 (1949).
Marvin D. Armstrong et al, "The Indole Acids of Human . . . Indole Acids", J. Biol. Chem., 232, 17 (1958).
Ernst Biekert et al, "Mannich-Kondensationen mit Glyoxylsaure", Ber., 97, 363-371 (1964).
N. Yoneda, "Synthesis of 12-methyl-. . . quinolizine", Chem. Pharm. Bull, 13, 1231-1240 (1965).
T. Kametani et al, "Studies on the Syntheses of Heterocyclic . . . Related Compounds", J. Heterocycl. Chem., 5, 799-804, (1968).
Shun-ichi Yamada et al, "Ind.-N-alkylation of Tryptophan . . . Hydrazides", Chem. Pharm. Bull., 13, 88-93 (1965).
Preobrazhenskaya et al, "Alpha-(3-indolyl)-beta-hydroxyamine and Its Derivatives", Khim. Geterotsikl. Soedin, 7, 778 (1971).
I. Arthur Mirsky et al, "The Hypoglycemic and . . . action of Tryptophan", Endocrinology, 59, 369 (1956).
I. Arthur Mirsky et al, "Hypoglycemic Action of . . . Tryptophan By Mouth", Endocrinology, 60, 318 (1957).
R. B. Sanders et al, "L-amino Acid Inhibition . . . Hyperglycemia", Pharmacology, 6, 155 (1971).
Agnes Szigeti et al., "Effects of Amino Acids on the Blood Sugar Levels", Nahrung, 13, 171 (1969).
Magdolna Bedo et al, "Interactions Between Some Nutrients and Metabolsm", Egeszegtudomany, 13, 249 (1969).
A. Lutkic et al, "Glycogen Formation and Structure . . . Metabolic States", Bull. Sci., Cons. Acad. Sci. Arts RSF Yougoslavie, Sect. A., 18, 8 (1973).
Jose A. Hedo et al, "Elevation of Plasma glucose . . . Ingestion in Man", Clin. Exp., 26, 1131 (1977).
James S. Whitmann III, "Alteration of Glucose Tolerance . . . in Rats", J. Nutr., 106, 631 (1976).
G. Carrozza et al, "Mechanism of the Intervention . . . in Glyconeogenesis", Boll. Soc. Ital. Bio. Sper., 47, 535 (1971).
Kay Tanaka et al, "Synergistic Hypoglycemis Effects . . . with Hypoglycin A", Pan-Am. Assoc. Biochem. Soc. Sypm., 3, 163 (1975).
Stephen A. Smith et al, "The hypoglycemic Action of Tryptophan in the Rat", Biochem. Soc. Trans., 4, 1049 (1976).
Stephan A. Smith et al, "Tryptophan and the Control of Plasma . . . in the Rat", Biochem. Soc. Trans., 168, 495 (1977).
Peter Lloyd et al, "Factors Affecting Trypophan-induced Hypoglycemia in Rats", Biochem. Pharmacol., 31, 3563 (1982).
H. G. McDaniel et al, "Hypoglycemic Action of Tryptophan", Diabetes, 22, 713 (1973).
Carlo M. Veneziale et al, "Influence of L-Tryptophan and Its Metabolites . . . Perfused Liver", Biochemistry, 6, 2129 (1967).
U. Butturini et al, "Hypoglycemic Action of L-tryptophan and Tolbutamide", Minerva Med., 1497 (1958).
Kozo Okamoto et al, "Prevention of Experimental Diabetes . . . Substances", Tohoku J. Exptl. Med., 61, Suppl. 3, 36 (1955).
Fred Howard et al, "Tryptophan and Blood-Sugar Levels", Am. J. Physiol., 153, 425 (1948).
V. G. Barone et al, "The Effect of Tyrosine and Tryptophan Administration to Diabetics", Boll. Soc. Ital. Soc. Sper. 6, 834 (1931).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

.alpha.-amino-indole-3-acetic acids useful as anti-diabetic, ant does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with .alpha.-amino-indole-3-acetic acids useful as anti-diabetic, ant, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and .alpha.-amino-indole-3-acetic acids useful as anti-diabetic, ant will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2028223

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.